ARWR Stock Analysis: Buy, Sell, or Hold?
ARWR - Arrowhead Research Corporation
$74.11
-2.29 (-3.00%)
▼
5d:
-14.37%
30d:
+4.78%
90d:
+13.77%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
23d
Smart Money Accumulation
None View Scanner →
Strength: 3.8/10
Get Alerted When ARWR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ARWR is down 14.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ARWR is down 14.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ARWR is currently trading at $74.11, which is considered oversold relative to its 30-day fair value range of $74.50 to $83.33.
Technical Outlook: Technically, ARWR is in a strong uptrend. The price is currently testing key support at $72.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $90.64 (+22.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARWR is in a strong uptrend. The price is currently testing key support at $72.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $90.64 (+22.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$74.50 -
$83.33
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding ARWR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.3% below Wall St target ($90.64)
- WARNING: Recommendation downgraded due to -14.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$74.50 -
$83.33
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$72.66
Resistance Level
$87.83
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.11
Wall Street Target
$90.64
(+22.3%)
Revenue Growth (YoY)
-86.4%
Earnings Growth (YoY)
9.8%
Profit Margin
-48.4%
Share & Embed Analysis
Last updated: July 13, 2026 6:02 PM ET
Data refreshes hourly during market hours. Next update: 7:02 PM
Data refreshes hourly during market hours. Next update: 7:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARWR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
James C Hamilton
SELL
10000 shares
2026-04-23
Daniel Joseph Apel
SELL
13095 shares
2026-04-22
James C Hamilton
SELL
10000 shares
2026-03-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 54 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
Advanced ARWR Option Strategies
Professional options setups generated by AI based on today's ARWR price and gamma walls.
